Newsroom
-
Jennifer Doudna’s diagnostic spinout raises Mammoth round as it expands to therapies
Endpoints NewsLearn More -
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
Business WireLearn More -
Mammoth Biosciences Named to Fierce Medtech’s “Fierce 15” Companies of 2020 for Advancing Next Generation CRISPR Products in Diagnostics and Therapeutics
WebWireLearn More -
Mammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms
WebWireLearn More -